Your browser doesn't support javascript.
loading
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.
Sachs, Stephan; Götz, Anna; Finan, Brian; Feuchtinger, Annette; DiMarchi, Richard D; Döring, Yvonne; Weber, Christian; Tschöp, Matthias H; Müller, Timo D; Hofmann, Susanna M.
Afiliación
  • Sachs S; Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany.
  • Götz A; Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich, Munich, Germany.
  • Finan B; Technische Universität München, 80333, Munich, Germany.
  • Feuchtinger A; Institute for Diabetes and Regeneration, Helmholtz Diabetes Center at Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764, Neuherberg, Germany.
  • DiMarchi RD; Institute for Diabetes and Obesity, Division of Metabolic Diseases, Helmholtz Diabetes Center at Helmholtz Centre Munich, Munich, Germany.
  • Döring Y; Novo Nordisk Research Center Indianapolis, Indianapolis, IN, USA.
  • Weber C; Research Unit Analytical Pathology, Helmholtz Center Munich, 85764, Neuherberg, Germany.
  • Tschöp MH; Department of Chemistry, Indiana University, Bloomington, IN, USA.
  • Müller TD; Department of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Hofmann SM; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University Munich, Munich, Germany.
Cardiovasc Diabetol ; 22(1): 217, 2023 08 17.
Article en En | MEDLINE | ID: mdl-37592302
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Aterosclerosis / Dislipidemias Límite: Animals Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Aterosclerosis / Dislipidemias Límite: Animals Idioma: En Revista: Cardiovasc Diabetol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania